Style Sampler

Layout Style

Patterns for Boxed Mode

Backgrounds for Boxed Mode

All fields are required.

Close Appointment form

Brian Mehling, M.D., and team travel to Monaco for potential investors

  • Home
  • Brian Mehling, M.D., and team travel to Monaco for potential investors

News

Brian Mehling, M.D., and team travel to Monaco for potential investors

Dec 02, 2021 by BHI

No Comments

Brian Mehling, M.D., M.S.founder and chief medical officer of Blue Horizon International (BHI) and his team traveled to Monaco and Paris, France in November 2021, attending a series of meetings with potential investors and partners to expand access to stem cell therapeutics.

#BlueHorizonStemCells #StemCellTherapy #Monaco #France

1

  • Share This

About the author

Related Posts

Submit a comment

Your email address will not be published. Required fields are marked *

Leave a Reply

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

About Blue Horizon International

Blue Horizon International is the world’s leading provider of adult and children’s stem cell therapies. We have safely and efficiently performed more than 4,000 stem cell therapies to date. We are the only treatment provider approved and associated with The Wuhan University Department of Medicine, The Biochemistry Institute of Wuhan University. We are fully licensed by the Ministry of Health of the Slovak Republic to offer cord blood, bone marrow and adipose stem cell derived treatments at Malacky Hospital near Bratislava, Slovakia.

Recent News
Address
Blue Horizon International, LLC 214 State Street, Suite 101 Hackensack, NJ 07601 | USA
Get in touch with us

© 2025 Blue Horizon International, LLC. All rights reserved. This website is only intended for consumers outside the United States.